Ostojic Marija Z,Djuric Ana,Zivic Kristina,Grahovac Jelena S (2024) Analysis of the nischarin expression across human tumor types reveals its context-dependent role and a potential as a target for drug repurposing in oncology, PLOS ONE, vol. 19, br. 5, str. - (Article) 

Grahovac Jelena S,Zivic Kristina,Galun Danijel A (2023) Nischarin can be a target for stromal normalisation in pancreatic ductal adenocarcinoma, ANNALS OF ONCOLOGY, vol. 34, br. , str. S198-S198 (Meeting Abstract) 

Ostojic Marija Z,Jevric Marko,Mitrovic-Ajtic Olivera S,Zivic Kristina,Tanic Miljana G,Cavic Milena R,Srdic-Rajic Tatjana V,Grahovac Jelena S (2023) Nischarin expression may have differing roles in male and female melanoma patients, JOURNAL OF MOLECULAR MEDICINE-JMM, vol. 101, br. 8, str. 1001-1014 (Article) 

Pavlovic Marijana,Ostojic Marija Z,Zivic Kristina,Pavic Aleksandar B,Srdic-Rajic Tatjana V,Grahovac Jelena S (2022) Nischarin agonist rilmenidine inhibits pancreatic ductal adenocarcinoma cell migration and invasion, CANCER RESEARCH, vol. 82, br. 12, str. - (Meeting Abstract) 

Cavic Milena R,Damjanovic Ana B,Boljevic Ivana Z,Pavlovic Marijana,Stefanovic Aleksandra,Zivic Kristina,Vukovic M,Tanic Miljana G,Jankovic Radmila N (2022) EGFR mutation testing from pleural effusions of advanced lung adenocarcinoma patients in Serbia, ANNALS OF ONCOLOGY, vol. 33, br. 7, str. S983-S983 (Meeting Abstract) 

Grahovac Jelena S,Pavlovic Marijana,Ostojic Marija Z,Zivic Kristina,Galun Danijel A,Srdic-Rajic Tatjana V (2021) Nischarin is expressed in pancreatic ductal adenocarcinoma and is a potential target for drug repurposing., CANCER RESEARCH, vol. 81, br. 22, str. 28-28 (Meeting Abstract)